Passage Bio

company

About

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.

Details

Last Funding Type
Series B
Last Funding Money Raised
$110M
Industries
Biotechnology,Health Care,Therapeutics,Wellness
Founded date
Jan 1, 2018
Number Of Employee
51 - 100
Operating Status
Active
Stock Symbol
nasdaq:PASG
Legal Name
Passage Bio Inc.

Passage Bio is a fully integrated gene therapy company with a mission to develop a portfolio of five life-transforming AAV-delivered therapeutics for the treatment of rare monogenic central nervous system diseases. The company is based in Philadelphia, PA and has a research, collaboration and license agreement with the University of Pennsylvania and its Gene Therapy Program (GTP) as well as the Orphan Disease Center (ODC). Pursuant to the research collaboration, GTP conducts IND-enabling preclinical work, and Passage Bio is responsible for clinical development, regulatory, manufacturing and commercialization of all product candidates. The ODC is responsible for natural history studies, KOL engagement, and patient advocacy outreach.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$595.50M
Passage Bio has raised a total of $595.50M in funding over 2 rounds. Their latest funding was raised on Jan 21, 2021 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 21, 2021 Post-IPO Equity $154M Detail
Feb 27, 2020 IPO $216M Detail
Sep 4, 2019 Series B $110M 11 Len Blavatnik Detail
Feb 15, 2019 Series A $115.50M 6 OrbiMed Detail

Investors

Number of Lead Investors
Number of Investors
2
11
Passage Bio is funded by 11 investors. Len Blavatnik and Boxer Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Len Blavatnik Yes Series B
Boxer Capital Series B
Frazier Healthcare Partners Series B
Highline Capital Management Series B
Lilly Asia Ventures Series B
Logos Capital Series B
New Leaf Venture Partners Series B
OrbiMed Series B
Sphera Funds Management Series B
Versant Ventures Series B

Employee Profiles

Number of Employee Profiles
11
Passage Bio has 11 current employee profiles, including Employee Liam Ratcliffe
Employee
Executive
Executive
Board member